Innovation
and Personalisation
of care for
hypercholesterolemia

 

 

Hypercholesterolemia :
it’s all about genes

 

 

Cardiovascular disease:
the number one cause
of death in France

 

 

Lowering LDL cholesterol
reduces the risk of cardiovascular events

 

Today in France, 1 person in every 300 suffers
from inherited hypercholesterolemia

 

The CHOPIN translational research project seeks to reduce cardiovascular risks
in patients by offering new personalised hypercholesterolemia treatment
 through the identification of new risk markers and therapeutic targets.

Academic and Industry partners

Clinical trials over 5 years

Patients involved

million euros obtained via the RHU call for projects

 

COORDINATION :

 

Privacy Preference Center

Nécessaires

Ce cookie est utilisé pour identifier une session utilisateur, il ne contient aucune données personnelles.

This cookie is used to identify a user session, it does not contain any personal data.

PHPSESSID

Analyse de traffic

Ces cookies servent à l'analyse de trafic du site.

These cookies are used to analyze the site's traffic.

_ga,_gat,_gat_gtag_UA-35621070-26,_gid

Multilingue

Ces cookies servent au bon fonctionnement du site en multilingue, notamment dans le but d'afficher le site dans la langue la plus adaptée pour vous.

These cookies are used for the proper functioning of the site in multilingual, especially for the purpose of displaying the site in the language most suitable for you.

_icl_current_language, wpml_referer_url

RGPD

gdpr[allowed_cookies],gdpr[consent_types]